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Abstract- 
Context: Ovarian tumors are the seventh most common cause of death by cancer among 
women. Serous carcinomas arise either de novo or from a fallopian tube which shows 
specific histopathological and immunohistochemical changes much prior to the 
development of the ovarian carcinoma.  It may be beneficial to detect these initial 
changes to make an early diagnosis of these cancers in high- risk individuals.  
Aims and objectives:  
1. To categorize the ovarian tumors in the last 10 years, (from 2006 to 2015) as per the 
WHO 2014 classification. 
2. To assess the utility of STIC and p53 staining patterns as precursor lesions for serous 
ovarian tumors diagnosed from January 2015 to December 2015. 
Methods and Material:  
       We tabulated all the of ovarian tumours and tumour-like lesions reported in the 
Department of Pathology, Christian Medical College, Vellore over a 10-year period 
(2006 -  2015). 
        In the other part of the study, we examined the pathological changes in fallopian 
tubal sections of 85 serous tumor cases and 10 controls reported durng the year 2015. 
Results: 
 Most of the ovarian tumors in our study population were benign. The common age 
at presentation was 35-49years. Epithelial tumors were the most common broad 
subgroup of ovarian tumors; of which serous tumors were more common than the 
others.   
 The STIC lesions in the fallopian tubes of serous ovarian tumors were seen more 
commonly seen in high grade serous carcinoma cases as compared with the other serous 
tumors.  
 Abnormal expressions of p53 by immunohistochemistry were exclusively seen in high 
grade serous carcinoma cases of all the serous tumors.  
Conclusions: 
1. Categorization of ovarian tumors in 10 years period:  The majority of the ovarian 
tumors were benign tumors (67%), followed by malignant tumors (29%) and 
borderline tumors (4%).  There was a wide range of age, from 4 months to 89 years 
with peak age group of 35-49 years (37%). Surface epithelial tumors were the most 
common – (1058, 65%), followed by germ cell tumors- (683, ~18%) and tumor like 
lesions- (392, 10%). Among the surface epithelial tumors, serous tumors were the 
commonest (42%) of which majority were high grade.  
2. STIC (serous tubal intraepithelial carcinoma) and p53 staining:      
 STIC was present in 30 /85 (41%) of all the serous tumors,   23/42 (55%) of high grade 
serous carcinomas (p= <0.01), and 7/43 (8%) of other serous tumors and none of the 
controls.  
 Abnormal p53 expression exclusively seen in the high grade serous  carcinomas:  
(20/42, 48%), (p<0.05).    
 STIC and abnormal p53 expressions might be the precursors of high grade serous 
carcinomas. p53 signature was seen only in 4/95 cases, which included, 3 high grade 
serous carcinoma cases and 1 control case. None of the benign or borderline cases 
showed p53 signatures. This finding also suggests that the high grade serous 
carcinomas have a different pathogenesis from that of the other types of serous tumors. 
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